Time in the therapeutic range, bleeding event, and their determinants in older patients with atrial fibrillation on warfarin in Ethiopia: multicenter cross-sectional study

BackgroundAtrial fibrillation (AF) poses significant thromboembolism and bleeding risks, especially in older adults. Warfarin continues to be a primary treatment option, and maintaining the Time in Therapeutic Range (TTR) is critical for ensuring its effectiveness. However, suboptimal TTR is associa...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Zenaw Debasu Addisu, Desalegn Getnet Demsie, Chernet Tafere, Taklo Simeneh Yazie, Destaw Endeshaw, Bereket Bahiru Tefera, Malede Berihun, Dessale Abate Beyene
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1541592/full